191 related articles for article (PubMed ID: 12719698)
1. Prevention of type 2 diabetes: are we ready?
Bouche C; Goldfine AB
Minerva Med; 2003 Feb; 94(1):9-18. PubMed ID: 12719698
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic prevention or delay of type 2 diabetes mellitus.
Anderson DC
Ann Pharmacother; 2005 Jan; 39(1):102-9. PubMed ID: 15562143
[TBL] [Abstract][Full Text] [Related]
3. Prevention of type 2 diabetes.
Lai LC
Malays J Pathol; 2002 Dec; 24(2):71-6. PubMed ID: 12887163
[TBL] [Abstract][Full Text] [Related]
4. Prevention of type 2 diabetes.
Yale JF
Int J Clin Pract Suppl; 2000 Oct; (113):35-9. PubMed ID: 11965830
[TBL] [Abstract][Full Text] [Related]
5. Prevention of type 2 diabetes in the prediabetic population.
Maji D; Roy RU; Das S
J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766
[TBL] [Abstract][Full Text] [Related]
6. Strategies to prevent type 2 diabetes.
Abuissa H; Bel DS; O'keefe JH
Curr Med Res Opin; 2005 Jul; 21(7):1107-14. PubMed ID: 16004680
[TBL] [Abstract][Full Text] [Related]
7. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological interventions in the prevention of type 2 diabetes.
Henness S
Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):166-9. PubMed ID: 17940436
[TBL] [Abstract][Full Text] [Related]
9. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.
Varo N; Vicent D; Libby P; Nuzzo R; Calle-Pascual AL; Bernal MR; Fernández-Cruz A; Veves A; Jarolim P; Varo JJ; Goldfine A; Horton E; Schönbeck U
Circulation; 2003 Jun; 107(21):2664-9. PubMed ID: 12742991
[TBL] [Abstract][Full Text] [Related]
10. Toward practical prevention of type 2 diabetes.
McCarty MF
Med Hypotheses; 2000 May; 54(5):786-93. PubMed ID: 10859688
[TBL] [Abstract][Full Text] [Related]
11. Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials.
Haffner SM
Int J Clin Pract Suppl; 2002 Jul; (129):33-9. PubMed ID: 12166604
[TBL] [Abstract][Full Text] [Related]
12. The prevention of type 2 diabetes: what is the evidence?
Chiasson JL; Brindisi MC; Rabasa-Lhoret R
Minerva Endocrinol; 2005 Sep; 30(3):179-91. PubMed ID: 16208307
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic agents in subjects with mild dysglycaemia: prevention or early treatment of type 2 diabetes?
Scheen AJ
Diabetes Metab; 2007 Feb; 33(1):3-12. PubMed ID: 17258489
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.
Caro JJ; Getsios D; Caro I; Klittich WS; O'Brien JA
Diabet Med; 2004 Nov; 21(11):1229-36. PubMed ID: 15498090
[TBL] [Abstract][Full Text] [Related]
15. Metformin for prevention of type 2 diabetes.
Hess AM; Sullivan DL
Ann Pharmacother; 2004; 38(7-8):1283-5. PubMed ID: 15150378
[TBL] [Abstract][Full Text] [Related]
16. Reflecting on type 2 diabetes prevention: more questions than answers!
Rosenstock J
Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
[TBL] [Abstract][Full Text] [Related]
17. Managing type 2 diabetes. A look at the newer agents.
Larmore SS
JAAPA; 1999 Jun; 12(6):47-8, 51-4, 57. PubMed ID: 10728087
[No Abstract] [Full Text] [Related]
18. Metformin and pioglitazone: Effectively treating insulin resistance.
Staels B
Curr Med Res Opin; 2006; 22 Suppl 2():S27-37. PubMed ID: 16914073
[TBL] [Abstract][Full Text] [Related]
19. Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease.
Bethel MA; Califf RM
Am J Cardiol; 2007 Mar; 99(5):726-31. PubMed ID: 17317381
[TBL] [Abstract][Full Text] [Related]
20. Impaired glucose tolerance and impaired fasting glucose.
Rao SS; Disraeli P; McGregor T
Am Fam Physician; 2004 Apr; 69(8):1961-8. PubMed ID: 15117017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]